Dr. Paulette Gabbai-Saldate, MD

Dr. Gabbai-Saldate practices at Scripps Mercy Hospital San Diego in San Diego, California, part of Scripps Health.

Dr. Gabbai-Saldate's NPI, 1902285596, was assigned on May 28, 2015. Dr. Gabbai-Saldate graduated from University of California, San Diego School of Medicine in 2015. Dr. Gabbai-Saldate holds California license A147117.

Dr. Gabbai-Saldate's primary practice is Scripps Mercy Hospital San Diego, at 4077 5th Ave, San Diego, CA 92103 in San Diego County. The practice phone is (619) 294-8111.

Dr. Gabbai-Saldate's primary practice is Scripps Mercy Hospital San Diego in San Diego, California, part of Scripps Health. Dr. Gabbai-Saldate is also affiliated with Scripps Memorial Hospital La Jolla. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Gabbai-Saldate to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gabbai-Saldate practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gabbai-Saldate's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gabbai-Saldate is board certified in hematology by the American Board of Internal Medicine. Dr. Gabbai-Saldate is licensed in California.

CMS data shows 253 Medicare services from Dr. Gabbai-Saldate across 5 procedure codes in 2024, for 156 Medicare patients. Medicare paid $17,756 for them. Every service was in an office.

CMS counts 156 Medicare patients who saw Dr. Gabbai-Saldate in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have cancer, and 67% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gabbai-Saldate's median patient age at 69, with 77% women.

In 2024, Dr. Gabbai-Saldate wrote 721 Medicare Part D claims for 222 patients. 79% of them were for generic drugs. CMS names the drug for 447 of them, across 15 drugs with 11 or more claims each, at $1,030,236 in total drug cost. In 2023, CMS named 49 claims across 3 drugs.

Dr. Gabbai-Saldate accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gabbai-Saldate as offering telehealth.

Dmand AI links 3 papers to Dr. Gabbai-Saldate, published from 2016 to 2023. Dr. Gabbai-Saldate's most frequent co-authors are Kathryn B. Bollin, MD, Frances A. Collichio, MD and Annie Pearl Im, MD.

CMS Open Payments shows 184 general payments to Dr. Gabbai-Saldate from 48 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 97% of the total. Merck Sharp & Dohme Corporation paid the most, $431.

Dr. Gabbai-Saldate graduated from University of California, San Diego School of Medicine in 2015.

Dr. Gabbai-Saldate is in network with 6 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.